46708-153 : Desvenlafaxine 100 mg Oral Tablet, Extended Release


NDC46708-153
Labeler: Alembic Pharmaceuticals Limited
Product Type: Human Prescription Drug
Drug Name:  Desvenlafaxine
Dosage Form: Oral Tablet, Extended Release
Application #: NDA204150
Rev. Date: 


NDC Package Codes:

  • 46708-153-30: 30 TABLET, EXTENDED RELEASE IN 1 BOTTLE (46708‑153‑30)
  • 46708-153-90: 90 TABLET, EXTENDED RELEASE IN 1 BOTTLE (46708‑153‑90)

Active Ingredients:

  • Desvenlafaxine

Dosage Strength:

  • 100 mg

Pharmaceutical Classes:

  • Norepinephrine Uptake Inhibitors [MoA]
  • Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
  • Serotonin Uptake Inhibitors [MoA]
  • Cytochrome P450 2D6 Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 46708-152 Desvenlafaxine 50 mg Oral Tablet, Extended Release by Alembic Pharmaceuticals Limited
  • 46708-251 Desvenlafaxine 50 mg Oral Tablet, Extended Release by Alembic Pharmaceuticals Limited
  • 46708-252 Desvenlafaxine 100 mg Oral Tablet, Extended Release by Alembic Pharmaceuticals Limited
  • 46708-540 Desvenlafaxine 50 mg Oral Tablet, Extended Release by Alembic Pharmaceuticals Limited
  • 46708-541 Desvenlafaxine 100 mg Oral Tablet, Extended Release by Alembic Pharmaceuticals Limited
  • 46708-542 Desvenlafaxine 25 mg Oral Tablet, Extended Release by Alembic Pharmaceuticals Limited
  • 0054-0400 Desvenlafaxine 50 mg Oral Tablet, Film Coated, Extended Release by West-ward Pharmaceuticals Corp.
  • 0054-0401 Desvenlafaxine 100 mg Oral Tablet, Film Coated, Extended Release by West-ward Pharmaceuticals Corp.
  • 0054-0603 Desvenlafaxine 25 mg Oral Tablet, Film Coated, Extended Release by West-ward Pharmaceuticals Corp.
  • 0378-4230 Desvenlafaxine 50 mg Oral Tablet, Film Coated, Extended Release by Mylan Pharmaceuticals Inc.
  • 0378-4231 Desvenlafaxine 100 mg Oral Tablet, Film Coated, Extended Release by Mylan Pharmaceuticals Inc.
  • 0591-3659 Desvenlafaxine 50 mg Oral Tablet, Extended Release by Actavis Pharma, Inc.
  • 0591-3660 Desvenlafaxine 100 mg Oral Tablet, Extended Release by Actavis Pharma, Inc.
  • 0591-4060 Desvenlafaxine 25 mg Oral Tablet, Extended Release by Actavis Pharma, Inc.
  • 35208-009 Desvenlafaxine 50 mg Oral Tablet, Extended Release by Intellipharmaceutics Corp.
  • 35208-010 Desvenlafaxine 100 mg Oral Tablet, Extended Release by Intellipharmaceutics Corp.
  • 47335-747 Desvenlafaxine 50 mg/1 Oral Tablet, Extended Release by Sun Pharma Global Fze
  • 47335-804 Desvenlafaxine 100 mg/1 Oral Tablet, Extended Release by Sun Pharma Global Fze
  • 50090-4388 Desvenlafaxine 25 mg Oral Tablet, Extended Release by A-s Medication Solutions
  • 50090-4806 Desvenlafaxine 50 mg Oral Tablet, Film Coated, Extended Release by A-s Medication Solutions
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 46708-153 QR Code

< Prev: 46708-152Next: 46708-177 >

Related Discussions:

Desvenlafaxine (Pristiq) and Simvastatin
For at least a year or more I've been taking pristiq (generic) and simvastatin at the same time. I felt that the pri... 4 replies
Desvenlafaxine and menstrual cramps
I just started on the generic Pristiq a little over a month ago and along with all the other side effects I've seen ... 1 reply
Alternatives to Exsira (desvenlafaxine) for depression
Are there any alternatives to Exsira (desvenlafaxine) for treating depression? I take it for this purpose and it works w...
what is desvenlafaxine and drugs contain it
took me off celexa and put me on pristique-is there any other medication that comes close to pristique,or is there any o...
flupentixol melitracen and desvenlafaxine side effects
For depression doctor has prescribed flupentixol melitracen tablet 1 and desvenlafaxine 2 in evening. i am experiencing ... 1 reply
Bromhexine hydrochloride and Desvenlafaxine
I have been taking 50mg Pristiq (desvenlafaxine) and want to know if I can take Bisolvon chesty with it? It contains bro...




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 18 October 2019.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA